Showing results (1421-1430 of 6,769) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|December 22, 2005
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controlsSergio Neri, Salvatore S Signorelli, Benedetto Torrisi, et al.Clinical Therapeutics|December 22, 2005
Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United KingdomPhil McEwan, Keshwar Baboolal, Pete Conway, et al.Clinical Therapeutics|May 1, 1997
Efficacy and tolerability of doxazosin versus enalapril in the treatment of patients with mild-to-moderate hypertensionK W Tan, S A FriseClinical Therapeutics|May 1, 1997
Effects of cilazapril on ventricular arrhythmia in patients with congestive heart failureY Hattori, S Atsushi, F Hiroaki, et al.Clinical Therapeutics|May 1, 1997
Bromfenac sodium, acetaminophen/oxycodone, ibuprofen, and placebo for relief of postoperative painG H Johnson, J D Van Wagoner, J Brown, et al.Clinical Therapeutics|May 1, 1997
Pharmacoeconomic applications of meta-analysis for single groups using antifungal onychomycosis lacquers as an exampleT R EinarsonClinical Therapeutics|May 1, 1997
Outcomes and costs of positron emission tomography: comparison of intravenous adenosine and intravenous dipyridamoleM J Holmberg, S M Mohiuddin, D E Hilleman, et al.Clinical Therapeutics|December 7, 2005
Pramlintide in the treatment of type 1 and type 2 diabetes mellitusGina J Ryan, Lynetta J Jobe, Rhonda MartinClinical Therapeutics|December 7, 2005
Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group studyVictor Lawrence Roberts, John Stewart, Maher Issa, et al.Clinical Therapeutics|December 7, 2005
Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group studyClifford J Bailey, Alfredas Bagdonas, Josip Rubes, et al.Pageof 677